EQS-Adhoc: Marinomed Biotech AG sets price range for potential 10% capital increase and potential second capital increase, in each case…
EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Corporate Action
Marinomed Biotech AG sets price range for potential 10% capital increase
and potential second capital increase, in each case excluding statutory
subscription rights
15-Sep-2024 / 17:49 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the
Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS
Group AG.
The issuer is solely responsible for the content of this announcement.!-->…